title: [The insulin therapy of patients with terminal chronic kidney failure].
abstract: Anabolic doses of intramuscular insulin significantly decrease blood content of fructose and glycolysed haemoglobin in patients with terminal chronic renal failure. At the same time, activity of amylase and gamma-glutamyl transpeptidase increases, number of insulin-carrying erythrocytes comes to the norm.
authors.forename: I B
authors.initials: IB
authors.lastname: Tychka
authors.forename: A V
authors.initials: AV
authors.lastname: Petrykiv
mesh_terms: D000293:Adolescent; D000328:Adult; D003131:Combined Modality Therapy; D006801:Humans; D007273:Injections, Intramuscular; D007328:Insulin / Q000008:administration & dosage* / Q000172:deficiency; D007676:Kidney Failure, Chronic / Q000097:blood / Q000188:drug therapy*; D008875:Middle Aged; D006435:Renal Dialysis
chemical_list: D007328:Insulin
vernacular_title: Insulinoterapiia khvorykh na terminal'noiu khronichnoiu nyrkovoiu nedostatnistiu.